EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Top advances of the year: Reappraisal of systemic versus local therapy for hepatocellular carcinoma

Mosunmoluwa Oyenuga, Tia McGrew iD, Lindsay M Hannan, Olatunji B Alese iD

Cancer · 2025-11 · 131 (21)

DOI: 10.1002/cncr.70162 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer, online erschienen am 02.11.2025. Verfasst von Mosunmoluwa Oyenuga und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) remains a leading cause of cancer‐related mortality worldwide. The most recent global cancer burden estimated almost 760,000 deaths in 2022 alone. Notable advances over the past year in the management of HCC include new options in systemic therapy and exciting data regarding combinations with locoregional therapies. Adjuvant systemic therapy for resectable HCC remains disappointing, highlighting the need for further understanding of predictive biomarkers. Additional insight into optimal treatment of unique populations and continued development of novel therapeutics are also highlighted in this review.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHumansChemoembolization, TherapeuticCombined Modality Therapy

Stichwörter der Autor:innen

hepatocellular carcinomaimmunotherapylocoregional therapiesnovel therapeuticsradioembolizationsystemic treatmenttransarterial chemoembolization

Autor:innen und Institutionen

  • Department of Hematology and Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia, USA.
  • Emory Healthcare, Winship Cancer Institute of Emory University, Atlanta, Georgia, USA.

ORCID-Profile: Tia McGrew, Olatunji B Alese

Zitieren

APA

Oyenuga, M., McGrew, T., Hannan, L. M., & Alese, O. B. (2025). Top advances of the year: Reappraisal of systemic versus local therapy for hepatocellular carcinoma. Cancer, 131(21). https://doi.org/10.1002/cncr.70162

Vancouver

Oyenuga M, McGrew T, Hannan LM, Alese OB. Top advances of the year: Reappraisal of systemic versus local therapy for hepatocellular carcinoma. Cancer. 2025;131(21). doi:10.1002/cncr.70162

BibTeX
@article{Oyenuga2025,
  author = {Oyenuga, Mosunmoluwa and McGrew, Tia and Hannan, Lindsay M and Alese, Olatunji B},
  title = {Top advances of the year: Reappraisal of systemic versus local therapy for hepatocellular carcinoma},
  journal = {Cancer},
  year = {2025},
  volume = {131},
  number = {21},
  doi = {10.1002/cncr.70162}
}
Kostenlos starten →